Correction to U.S. Sues Mallinckrodt Article on March 3
14 Junio 2021 - 1:30PM
Noticias Dow Jones
The Justice Department alleged that Mallinckrodt ARD LLC,
started calculating and paying rebates as if Acthar was a new drug
first marketed in 2013 after the Food and Drug Administration
approved a new indication for its use in 2010. "U.S. Sues
Mallinckrodt for Allegedly Underpaying Medicaid Rebates," on March
3, 2020, incorrectly referred to the agency as the federal drug
administration.
(END) Dow Jones Newswires
June 14, 2021 14:26 ET (18:26 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Mallinckrodt () (USOTC:MNKKQ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Mallinckrodt () (USOTC:MNKKQ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Mallinckrodt Plc () (OTCMarkets): 0 recent articles
Más de Mallinckrodt Plc (PK) Artículos de Noticias